News for Lexicon Pharmaceuticals, Inc. (LX31.F)

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Feb. 2) Argenx ...

Biotech stocks advanced in the week ended Jan. 15, defying the softness experienced by the broader market. Pre-announcements continued to pour in,...

Biotech stocks advanced in the week ended Jan. 15, defying the softness experienced by the broader market. Pre-announcements continued to pour in, with most ...

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Jan. 14) 10X ...

Today's Daily Dose brings you news about Lexicon's regulatory update on Sotagliflozin in heart failure; FDA approval of Pfizer's XALKORI in a new indication; Bicycle's pipeline progress update and Organogenesis' progress in knee osteoarthritis trial.

Toward the end of trading Thursday, the Dow traded up 0.24% to 31,135 while the NASDAQ rose 0.27% to 13,164.28. The S&P also rose, gaining 0.08% to ...

Midway through trading Thursday, the Dow traded up 0.42% to 31,189.88 while the NASDAQ rose 0.35% to 13,175.48. The S&P also rose, gaining 0.15% to ...

Viveve Medical Inc is a women\’s sexual health company focused on the commercialization of a non-surgical, non-ablative medical device that remodels collagen ...

Following the market opening Thursday, the Dow traded up 0.43% to 31,195.15 while the NASDAQ rose 0.53% to 13,199.16. The S&P also rose, gaining 0.32% ...

Shares of Lexicon Pharmaceuticals, Inc. (LXRX) are currently gaining over 35% after the company said it received a regulatory feedback that clears a key hurdle for partnership discussions around sotagliflozin in heart failure.

Biotech Penny Stocks to Watch Friday, January 8th was a relatively good day for many penny stocks. After a week of volatility in the stock market, Friday repre...